Journal of Mid-Life Health (Jan 2022)

Metabolic syndrome and its components: A cross-sectional analysis of its distribution among pre- and post-menopausal women from Northern India

  • R Nandhini,
  • Banashree Nath,
  • Harsha S Gaikwad,
  • Manjula Sharma,
  • Snehlata Meena

DOI
https://doi.org/10.4103/jmh.jmh_38_22
Journal volume & issue
Vol. 13, no. 4
pp. 310 – 316

Abstract

Read online

Aim: This study aims to determine the prevalence of Metabolic Syndrome (MS) and recognize its abnormal components in pre and postmenopausal women. We also aim to recognize the abnormal components in postmenopausal women with regard to duration since menopause. Materials and Methods: The cross-sectional study was undertaken among pre- and post-menopausal women between 40 and 65 years. Women with MS were identified as per the modified National Cholesterol Education Program Adult Treatment Panel III. Results: A total of 220 women were enrolled comprising 112 premenopausal and 108 postmenopausal women, the prevalence of MS among them being 33% and 51.85%, respectively. Postmenopausal status was found to be independently associated with MS when adjusted for potential confounders (adjusted odds ratios = 14.77, 95% confidence intervals: 1.77–23.33). All the components were proportionately higher in postmenopausal group, the rise in blood pressure (BP) (P = 0.003) and low high-density lipoprotein (HDL) (0.027) being statistically significant. The risk of MS, abdominal obesity, and high BP were highest in <5 years since menopause and decreased thereafter. The risk for low HDL and high triglyceride increased with the number of years since menopause, reaching the peak level in the 5–9-year group and then decreased while the risk of high fasting blood sugar increased reaching peak in the 10–14 years' group. Conclusion: The prevalence of MS is significantly high in postmenopausal women. Screening of women in premenopausal period will give an opportunity to intervene and prevent the menace of MS in Indian women predisposed to abdominal obesity, insulin resistance, and cardiovascular adverse events.

Keywords